Download by
Scanning QR Code
No Data
CN Stock MarketDetailed Quotes
688606 Hangzhou Alltest Biotech
Watchlist
61.69
+2.81+4.77%
Market Closed 09/28 15:00 CST
61.96High57.55Low20.30KlotVolume
58.88Open58.88Pre Close122.66MTurnover5.42%Turnover RatioLossP/E (TTM)4.89BMarket Cap89.6752wk High4.13P/E (Static)79.28MShares46.0252wk Low1.31P/B2.31BFloat Cap149.94Historical High70.66Limit Up37.46MShs Float46.02Historical Low47.10Limit Down7.49%Amplitude9.27KlotAsk6.76Dividend TTM60.43Avg Price10.34KlotBid10.95%Div YieldTTM100Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Hangzhou Alltest Biotech Company
The company is a high-tech enterprise located in Hangzhou Economic and Technological Development Zone, a national development zone. Aotai Park covers an area of 25 acres and currently has 26,000 square meters of factory and office space. Aotai Biotech focuses on the POCT segment of the in vitro diagnostic industry, and its main business is R&D, production and sales of in vitro diagnostic reagents. The company's main products are POCT rapid test reagent products such as drug and drug abuse testing series, infectious disease testing series, women's health testing series, tumor testing series, heart marker testing series and other testing series. Corporate honors: Hangzhou Enterprise Technology Center, High-tech Enterprise, Hangzhou High-tech Enterprise R&D Center (industrial category), Hangzhou “three-star” headquarters enterprise, etc.
News
Aotai Biotech (688606.SH): At a cost of 22.641,600 yuan, a total of 400,000 shares have been repurchased
Glonghui September 27丨Aotai Biotech (688606.SH) announced that as of the close of trading on September 27, 2023, the company had repurchased 400,000 shares of the company through centralized bidding through the Shanghai Stock Exchange trading system, accounting for 0.5045% of the company's total share capital of 79,280,855 shares. The highest repurchase price was 58.01 yuan/share, the lowest price was 55.11 yuan/share, and the total amount of capital paid was RMB 22.641,600 (excluding transaction fees such as stamp duty and transaction fees).
Aotai Biotech (688606.SH): The company has not implemented a share repurchase
Glonghui September 4 丨 Aotai Biotech (688606.SH) announced that as of August 31, 2023, the company has not implemented a share repurchase.
Aotai Biotech (688606.SH) released semi-annual results, net profit of 71.18 million yuan, a year-on-year decrease of 94.54%
Aotai Biotech (688606.SH) disclosed the 2023 semi-annual report. The company achieved revenue of 3.88 during the reporting period...